Model
Edge
Alnylam Pharmaceuticals, Inc.
0001298814
Filing type
4
Filing date
Feb 26, 2023
Updated
Feb 27, 2023 ยท 9:11 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership